Journal
ATHEROSCLEROSIS
Volume 270, Issue -, Pages 199-204Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2017.12.025
Keywords
TRPC3; Macrophage; Vascular calcification
Funding
- NIH [R56HL125619]
- Intramural Research Program (NIH Project) [Z01-ES-101864]
Ask authors/readers for more resources
Background and aims: Recent in vitro studies have showed that in macrophages, deletion of the nonselective Ca2+-permeable channel TRPC3 impairs expression of the osteogenic protein BMP-2. The pathophysiological relevance of this effect in atherosclerotic plaque calcification remains to be determined. Methods: We used Ldlr(-/-) mice with macrophage-specific loss of TRPC3 (MacTrpc3(-/-)/Ldlr(-/-)) to examine the effect of macrophage Trpc3 on plaque calcification and osteogenic features in advanced atherosclerosis. Results: After 25 weeks on high fat diet, aortic root plaques in MacTrpc3(-/-)/Ldlr(-/-) mice showed reduced size, lipid and macrophage content compared to controls. Plaque calcification was decreased in MacTrpc3(-/-)/Ldlr(-/-) mice, and this was accompanied by marked reduction in BMP-2, Runx-2 and phospho-SMAD1/5 contents within macrophage-rich areas. Expression of Bmp-2 and Runx-2 was also reduced in bone marrow-derived macrophages from MacTrpc3(-/-)/Ldlr(-/-) mice. Conclusions: These findings show that, in advanced atherosclerosis, selective deletion of TRPC3 in macrophages favors plaque regression and impairs the activity of a novel macrophage-associated, BMP-2-dependent mechanism of calcification. (c) 2017 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available